U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301437) titled 'RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.' on Dec. 11.

Brief Summary: To evaluate the differences in weight loss between liraglutide monotherapy and combined with orlistat in overweight/obese patients.

Study Start Date: Jan. 01, 2026

Study Type: INTERVENTIONAL

Condition: Overweight and Obese Adults

Intervention: DRUG: liraglutide monotherapy

liraglutide monotherapy

DRUG: liraglutide combined with orlistat

combination therapy

Recruitment Status: NOT_YET_RECRUITING

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Disclaimer: C...